Alleviation of insulitis and moderation of diabetes in NOD mice following treatment with a synthetic Pseudomonas aeruginosasignal molecule, N-(3-oxododecanoyl)-L-homoserine lactone

被引:20
作者
Pritchard, DI
Todd, I
Brown, A
Bycroft, BW
Chhabra, SR
Williams, P
Wood, P
机构
[1] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England
[2] Univ Nottingham, Sch Med, Div Immunol, Nottingham NG7 2UH, England
[3] Univ Nottingham, Ctr Biomol Sci, Nottingham NG7 2RD, England
[4] Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England
关键词
autoimmunity; therapeutics; pancreas; mononuclear leucocytes;
D O I
10.1007/s00592-005-0190-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Quorum sensing signal molecules (QSSMs) from the bacterium Pseudomonas aeruginosa control bacterial population density and the expression of virulence determinants. Coincidentally, and possibly to allow this pathogen to gain a foothold in the human body, certain signal molecules also downregulate immunological responses in an apparently T-helper 1-selective manner, which would suggest their application as therapeutics to some autoimmune diseases. In the present paper, experiments are described that indicate that one particular signal molecule, a synthetic N-(3-oxododecanoyl)-L-homoserine lactone, can be used to alleviate insulitis and diabetes in non-obese diabetic (NOD) mice, suggesting that bacterial signal molecules may represent a novel source of immune modulatory compounds for the treatment of type 1 diabetes, which afflicts more than 2 million individuals in Europe and North America.
引用
收藏
页码:119 / 122
页数:4
相关论文
共 11 条
[1]   Type 1 diabetes: new perspectives on disease pathogenesis and treatment [J].
Atkinson, MA ;
Eisenbarth, GS .
LANCET, 2001, 358 (9277) :221-229
[2]   Troglitazone prevents insulin dependent diabetes in the non-obese diabetic mouse [J].
Beales, PE ;
Liddi, R ;
Giorgini, AE ;
Signore, A ;
Procaccini, E ;
Batchelor, K ;
Pozzilli, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 357 (2-3) :221-225
[3]   A dual role for TNF-α in type 1 diabetes:: Islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis [J].
Christen, U ;
Wolfe, T ;
Möhrle, U ;
Hughes, AC ;
Rodrigo, E ;
Green, EA ;
Flavell, RA ;
von Herrath, MG .
JOURNAL OF IMMUNOLOGY, 2001, 166 (12) :7023-7032
[4]   Cytokines that regulate autoimmune responses [J].
Falcone, M ;
Sarvetnick, N .
CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (06) :670-676
[5]   DIMETHYL-SULFOXIDE MODULATION OF DIABETES ONSET IN NOD MICE [J].
KLANDORF, H ;
CHIRRA, AR ;
DEGRUCCIO, A ;
GIRMAN, DJ .
DIABETES, 1989, 38 (02) :194-197
[6]  
MIYAZAKI A, 1985, CLIN EXP IMMUNOL, V60, P622
[7]   PREVENTIVE EFFECTS OF CYCLOSPORINE ON DIABETES IN NOD MICE [J].
MORI, Y ;
SUKO, M ;
OKUDAIRA, H ;
MATSUBA, I ;
TSURUOKA, A ;
SASAKI, A ;
YOKOYAMA, H ;
TANASE, T ;
SHIDA, T ;
NISHIMURA, M ;
TERADA, E ;
IKEDA, Y .
DIABETOLOGIA, 1986, 29 (04) :244-247
[8]  
PRITCHARD DI, 2003, ADV MOL CELLULAR MIC, P201
[9]   IFN-γ/TNF-α synergism as the final effector in autoimmune diabetes:: A key role for STAT1/IFN regulatory factor-1 pathway in pancreatic β cell death [J].
Suk, K ;
Kim, S ;
Kim, YH ;
Kim, KA ;
Chang, I ;
Yagita, H ;
Shong, M ;
Lee, MS .
JOURNAL OF IMMUNOLOGY, 2001, 166 (07) :4481-4489
[10]   Cytokine production in Linomide-treated NOD mice and the potential role of a Th1/Th2 shift on autoimmune and anti-inflammatory processes [J].
Weiss, L ;
Barak, V ;
Zeira, M ;
Abdul-Hai, A ;
Raibstein, I ;
Reich, S ;
Hirschfeld, E ;
Gross, DJ ;
Slavin, S .
CYTOKINE, 2002, 19 (02) :85-93